The world's largest drug maker, Pfizer has announced that it intends to fast track its inhaled insulin Exubera in India. The world's largest drug maker, Pfizer has announced that it intends to ...
New Delhi: India is set to see the launch of Afrezza—the only rapid-acting, inhaled insulin to help control high blood sugar in adults with type 1 or type 2 diabetes—ten years after the ...
Insulin resistance is a significant health issue impacting various areas of the body, from heart health to brain function. It often goes unnoticed until serious health issues arise. Early ...
More than half of people with type 2 diabetes live in China, India and the US It has been ... that occurs when the body cannot produce enough insulin to regulate blood sugar levels.